-- Scott Roberts
MONDAY, June 20 (HealthDay News) -- Oxecta, an abuse-resistant
form of the top-selling painkiller oxycodone, has been approved by
the U.S. Food and Drug Administration.
The immediate-release medication contains niacin, which is
designed to cause uncomfortable flushing and skin irritation if a
person takes more than the recommended amount. Oxecta is similar to
Purdue Pharma's best-selling prescription painkiller Oxycontin, a
long-acting opioid drug that's commonly abused.
Oxecta shouldn't be used in people who have severe asthma,
upper-airway obstruction or chronic obstructive pulmonary disease
(COPD), drug makers Pfizer and Acura Pharmaceuticals said in a news
release. Common adverse reactions include nausea, constipation,
vomiting, headache, itchiness, insomnia, dizziness and lack of
energy, the companies said.
Pfizer is based in New York City, and Acura in Palatine,
The National Library of Medicine has more about
Please be aware that this information is provided to supplement the care provided by your physician. It is neither intended nor implied to be a substitute for professional medical advice. CALL YOUR HEALTHCARE PROVIDER IMMEDIATELY IF YOU THINK YOU MAY HAVE A MEDICAL EMERGENCY. Always seek the advice of your physician or other qualified health provider prior to starting any new treatment or with any questions you may have regarding a medical condition.
Copyright © EBSCO Publishing. All rights reserved.